Pancreatic Neuroendocrine Tumors
636 articles
Let’s Win! Pancreatic Cancer Updates Clinical Trials Section
Let’s Win announces updates to its clinical trials section on its website. These include a new clinical trial finder, animations,and educational pages.
LET’S WIN! PANCREATIC CANCER Turns 5!
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.
Let’s Win Rings the Nasdaq Closing Bell for Pancreatic Cancer Awareness Month
Let’s Win marked Pancreatic Cancer Awareness Month by ringing the closing bell at the Nasdaq Stock Market on Monday November 12, 2018.
Let’s Win Pancreatic Cancer Launches an Updated Platform
Let’s Win Pancreatic Cancer has launched its new website, with more ways for patients and caregivers to find important information they need.
Let’s Win! Pancreatic Cancer Long PSA
Part of winning the battle against pancreatic cancer is to hope. Join us to learn about upcoming science and read My Treatment stories from patients.
A Vaccine To Boost Immune Response to Pancreatic Cancer
Researchers are testing whether a vaccine can heighten the body’s immune response to pancreatic cancer after surgical removal of the tumor.
Clinical Trial For OncoTreat Being Developed
Researcher Kenneth Olive is developing OncoTreat, a method matches a patient’s tumor to the most effective drugs for their pancreatic cancer.
Targeted Therapy for Cancers Carrying the PALB2 Mutation
Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.